REQUEST A DEMO
Total
USD $0.00
Search more companies

Immuneonco Biopharmaceuticals (Shanghai) Inc. (China)

Main Activities: All Other Professional, Scientific, and Technical Services
Full name: Immuneonco Biopharmaceuticals (Shanghai) Inc. Profile Updated: March 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

ImmuneOnco Biopharmaceuticals Shanghai Inc is a company mainly engaged in research and development of testing biotechnology. The Company's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The company was established in 2015 and is headquartered in Shanghai City, China.

Headquarters
Unit 15, 1000 Zhangheng Road, China (Shanghai) Pilot Free Trade Zone, Pudong New Area
Shanghai; Shanghai;

Contact Details: Purchase the Immuneonco Biopharmaceuticals (Shanghai) Inc. report to view the information.

Website: http://www.immuneonco.com

Basic Information
Outstanding Shares:
Purchase the Immuneonco Biopharmaceuticals (Shanghai) Inc. report to view the information.
Financial Auditors:
Purchase the Immuneonco Biopharmaceuticals (Shanghai) Inc. report to view the information.
Incorporation Date:
2015
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
9.4%
Purchase this report to view the information.
2.08%
Purchase this report to view the information.
1.49%
Subsidiaries
Immuneonco Hong Kong Limited (Hong Kong SAR, China)
100%
Immuneonco Pharmaceutical Biological (Shanghai) Co., Ltd
100%
Immunetank Biopharmaceuticals (Shanghai) Co., Ltd
100%
Company Performance
Financial values in the chart are available after Immuneonco Biopharmaceuticals (Shanghai) Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-28.25%
Total operating revenue
37.64%
Operating profit (EBIT)
-1.71%
EBITDA
-2.11%
Net Profit (Loss) for the Period
5.82%
Total assets
4.12%
Total equity
-3.97%
Operating Profit Margin (ROS)
-29665.91%
Net Profit Margin
-23418.08%
Return on Equity (ROE)
0.99%
Debt to Equity Ratio
8.11%
Quick Ratio
-6.68%
Cash Ratio
-9.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?